Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""T-cell"" wg kryterium: Temat


Tytuł :
Comprehensive genomic analysis identifying heterogeneity in peripheral T-cell lymphoma.
Autorzy :
Yoshida N; Department of Clinical Studies, Radiation Effects Research Foundation, Hiroshima, Japan.; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
Yamada K; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
Ohshima K; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Apr; Vol. 112 (4), pp. 1339-1347. Date of Electronic Publication: 2021 Feb 25.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Lymphoma, T-Cell, Peripheral/*genetics
Animals ; Genomics/methods ; HTLV-I Infections/genetics ; Human T-lymphotropic virus 1/pathogenicity ; Humans ; Leukemia-Lymphoma, Adult T-Cell/genetics ; Leukemia-Lymphoma, Adult T-Cell/virology ; Lymphoma, T-Cell, Peripheral/virology ; Receptors, Antigen, T-Cell/genetics
Czasopismo naukowe
Tytuł :
Follicular T-cell lymphoma mimicking lymphocyte-rich classic Hodgkin lymphoma: a case report of a diagnostic pitfall.
Autorzy :
Sakakibara A; Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.
Suzuki Y; Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.
Kato H; Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan.
Yamamoto K; Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan.
Sakata-Yanagimoto M; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan.
Ishikawa Y; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Furukawa K; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Shimada K; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kohno K; Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
Nakamura S; Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.
Satou A; Department of Surgical Pathology, Aichi Medical University Hospital, Nagakute, Japan.
Kato S; Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan.
Pokaż więcej
Źródło :
Journal of clinical and experimental hematopathology : JCEH [J Clin Exp Hematop] 2021 Jun 05; Vol. 61 (2), pp. 97-101. Date of Electronic Publication: 2021 Mar 15.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Hodgkin Disease/*diagnosis
Lymphoma, Follicular/*diagnosis
Lymphoma, T-Cell/*diagnosis
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor ; Humans ; Lymphoma, Follicular/genetics ; Lymphoma, Follicular/pathology ; Lymphoma, T-Cell/genetics ; Lymphoma, T-Cell/pathology ; Male ; Middle Aged ; T-Lymphocytes/pathology
Czasopismo naukowe
Tytuł :
CD8 T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity.
Autorzy :
Nguyen THO; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Rowntree LC; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Petersen J; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia; Australian Research Council Centre of Excellence for Advanced Molecular Imaging, Monash University, Clayton, VIC 3800, Australia.
Chua BY; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia; Global Station for Zoonosis Control, Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University, Sapporo 060-0808, Japan.
Hensen L; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Kedzierski L; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia; Faculty of Veterinary and Agricultural Sciences, University of Melbourne, Melbourne, VIC 3000, Australia.
van de Sandt CE; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia; Department of Hematopoiesis, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam 1066CX, the Netherlands.
Chaurasia P; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
Tan HX; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Habel JR; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Zhang W; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Allen LF; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Earnest L; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Mak KY; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Juno JA; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Wragg K; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Mordant FL; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Amanat F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Mifsud NA; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
Doolan DL; Centre for Molecular Therapeutics, Australian Institute of Tropical Health & Medicine, James Cook University, Cairns, QLD 4870, Australia.
Flanagan KL; School of Health Sciences and School of Medicine, University of Tasmania, Launceston, TAS 7248, Australia; Department of Immunology and Pathology, Monash University, Commercial Road, Melbourne, VIC 3004, Australia; School of Health and Biomedical Science, RMIT University, Melbourne, VIC 3000, Australia; Tasmanian Vaccine Trial Centre, Clifford Craig Foundation, Launceston General Hospital, Launceston, TAS 7250, Australia.
Sonda S; School of Health Sciences and School of Medicine, University of Tasmania, Launceston, TAS 7248, Australia.
Kaur J; School of Health Sciences and School of Medicine, University of Tasmania, Launceston, TAS 7248, Australia; Tasmanian Vaccine Trial Centre, Clifford Craig Foundation, Launceston General Hospital, Launceston, TAS 7250, Australia.
Wakim LM; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Westall GP; Lung Transplant Unit, Alfred Hospital, Melbourne, VIC 3004, Australia.
James F; Department of Infectious Diseases, Austin Hospital, Heidelberg, VIC 3084, Australia.
Mouhtouris E; Department of Infectious Diseases, Austin Hospital, Heidelberg, VIC 3084, Australia.
Gordon CL; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia; Department of Infectious Diseases, Austin Hospital, Heidelberg, VIC 3084, Australia.
Holmes NE; Department of Infectious Diseases, Austin Hospital, Heidelberg, VIC 3084, Australia; Department of Medicine and Radiology, The University of Melbourne, Parkville, VIC 3000, Australia; Data Analytics Research and Evaluation (DARE) Centre, Austin Health and The University of Melbourne, Heidelberg, VIC 3084, Australia.
Smibert OC; Department of Infectious Diseases, Austin Hospital, Heidelberg, VIC 3084, Australia; Department of Infectious Diseases, Peter McCallum Cancer Centre, Melbourne, VIC 3000, Australia; The National Centre for Infections in Cancer, Peter McCallum Cancer Centre, Melbourne, VIC 3000, Australia.
Trubiano JA; Department of Infectious Diseases, Peter McCallum Cancer Centre, Melbourne, VIC 3000, Australia; The National Centre for Infections in Cancer, Peter McCallum Cancer Centre, Melbourne, VIC 3000, Australia; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases Austin Health, Heidelberg, VIC 3084, Australia; Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC 3084, Australia.
Cheng AC; Infection Prevention and Healthcare Epidemiology Unit, Alfred Health, Melbourne, VIC 3004, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC 3004, Australia.
Harcourt P; AFL House, Melbourne, VIC 3001, Australia.
Clifton P; AFL House, Melbourne, VIC 3001, Australia.
Crawford JC; Department of Immunology, St Jude Children's Research Hospital, Memphis, TN 38105, USA.
Thomas PG; Department of Immunology, St Jude Children's Research Hospital, Memphis, TN 38105, USA.
Wheatley AK; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, VIC 3000, Australia.
Kent SJ; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, VIC 3000, Australia; Melbourne Sexual Health Centre, Infectious Diseases Department, Alfred Health, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia.
Rossjohn J; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia; Australian Research Council Centre of Excellence for Advanced Molecular Imaging, Monash University, Clayton, VIC 3800, Australia; Institute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, United Kingdom.
Torresi J; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Kedzierska K; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia; Global Station for Zoonosis Control, Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University, Sapporo 060-0808, Japan. Electronic address: .
Pokaż więcej
Źródło :
Immunity [Immunity] 2021 May 11; Vol. 54 (5), pp. 1066-1082.e5. Date of Electronic Publication: 2021 Apr 15.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
CD8-Positive T-Lymphocytes/*immunology
COVID-19/*immunology
Coronavirus Nucleocapsid Proteins/*immunology
Immunodominant Epitopes/*immunology
Receptors, Antigen, T-Cell/*immunology
SARS-CoV-2/*immunology
Adult ; Aged ; Amino Acid Motifs ; CD4-Positive T-Lymphocytes ; Child ; Convalescence ; Coronavirus Nucleocapsid Proteins/chemistry ; Epitopes, T-Lymphocyte/chemistry ; Epitopes, T-Lymphocyte/immunology ; Female ; Humans ; Immunodominant Epitopes/chemistry ; Male ; Middle Aged ; Phenotype ; Phosphoproteins/chemistry ; Phosphoproteins/immunology ; Receptors, Antigen, T-Cell/chemistry ; Receptors, Antigen, T-Cell/genetics ; Receptors, Antigen, T-Cell, alpha-beta/chemistry ; Receptors, Antigen, T-Cell, alpha-beta/genetics ; Receptors, Antigen, T-Cell, alpha-beta/immunology ; Spike Glycoprotein, Coronavirus/chemistry ; Spike Glycoprotein, Coronavirus/immunology
Czasopismo naukowe
Tytuł :
T-cell receptor repertoire of cytomegalovirus-specific cytotoxic T-cells after allogeneic stem cell transplantation.
Autorzy :
Toya T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan. .
Taguchi A; Department of Obstetrics and Gynecology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. .; Department of Gynecology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan. .
Kitaura K; Repertoire Genesis Inc., Ibaraki, Japan.
Misumi F; Department of Obstetrics and Gynecology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Nakajima Y; Department of Radiation Oncology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.; Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Otsuka Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Konuma R; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Adachi H; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Wada A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Kishida Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Konishi T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Nagata A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Yamada Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Marumo A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Noguchi Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Yoshifuji K; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Mukae J; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Inamoto K; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Igarashi A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Najima Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Kobayashi T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Kakihana K; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Ohashi K; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Suzuki R; Repertoire Genesis Inc., Ibaraki, Japan.
Nagamatsu T; Department of Obstetrics and Gynecology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2020 Dec 17; Vol. 10 (1), pp. 22218. Date of Electronic Publication: 2020 Dec 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
T-Cell Antigen Receptor Specificity*
Cytomegalovirus/*immunology
Cytomegalovirus Infections/*etiology
Cytomegalovirus Infections/*metabolism
Hematopoietic Stem Cell Transplantation/*adverse effects
Receptors, Antigen, T-Cell/*metabolism
T-Lymphocytes, Cytotoxic/*immunology
T-Lymphocytes, Cytotoxic/*metabolism
Adult ; Aged ; Biomarkers ; Clonal Evolution ; Disease Susceptibility/immunology ; Female ; Humans ; Immunophenotyping ; Male ; Middle Aged ; Receptors, Antigen, T-Cell/genetics ; Transplantation Immunology ; Transplantation, Homologous ; Young Adult
Czasopismo naukowe
Tytuł :
SIX6 is a TAL1-regulated transcription factor in T-ALL and associated with inferior outcome.
Autorzy :
Laukkanen S; Faculty of Medicine and Health Technology, Tampere Center for Child Health Research, Tampere University, Tampere, Finland.
Oksa L; Faculty of Medicine and Health Technology, Tampere Center for Child Health Research, Tampere University, Tampere, Finland.
Nikkilä A; Faculty of Medicine and Health Technology, Tampere Center for Child Health Research, Tampere University, Tampere, Finland.
Lahnalampi M; The Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
Parikka M; Faculty of Medicine and Health Technology, BioMediTech, Tampere University, Tampere, Finland.; Oral and Maxillofacial Unit, Tampere University Hospital, Tampere, Finland.
Seki M; Department of Cell and Molecular Biology, Karolinska Institutet, Solna, Sweden.
Takita J; Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Degerman S; Department of Medical Biosciences and Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
de Bock CE; Children's Cancer Institute, Lowy Cancer Research Centre, Sydney, Australia.; School of Women's and Children's Health, University of New South Wales Sydney, Sydney, Australia.
Heinäniemi M; The Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
Lohi O; Faculty of Medicine and Health Technology, Tampere Center for Child Health Research, Tampere University, Tampere, Finland.; Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2020 Dec; Vol. 61 (13), pp. 3089-3100. Date of Electronic Publication: 2020 Aug 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Animals ; Basic Helix-Loop-Helix Transcription Factors/genetics ; Cell Line, Tumor ; Homeodomain Proteins ; Humans ; Proto-Oncogene Proteins/genetics ; T-Cell Acute Lymphocytic Leukemia Protein 1 ; Trans-Activators ; Zebrafish/genetics
Czasopismo naukowe
Tytuł :
ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells.
Autorzy :
Amatore F; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique U7258, Aix Marseille Université, Institut Paoli-Calmettes, Marseille, France.; Department of Dermatology and Skin Cancers, Hôpital de la Timone, Aix Marseille Université, Marseille, France.; Department of Dermatology, Aix Marseille University, Assistance Publique-Hôpitaux de Marseille, Hôpital Nord, Marseille, France.
Ortonne N; Department of Pathology and INSERM U955 Team 9 and.
Lopez M; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique U7258, Aix Marseille Université, Institut Paoli-Calmettes, Marseille, France.
Orlanducci F; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique U7258, Aix Marseille Université, Institut Paoli-Calmettes, Marseille, France.
Castellano R; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique U7258, Aix Marseille Université, Institut Paoli-Calmettes, Marseille, France.
Ingen-Housz-Oro S; Department of Dermatology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Henri-Mondor, Créteil, France.
De Croos A; Department of Pathology and INSERM U955 Team 9 and.
Salvado C; Department of Pathology and INSERM U955 Team 9 and.
Gorvel L; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique U7258, Aix Marseille Université, Institut Paoli-Calmettes, Marseille, France.
Goubard A; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique U7258, Aix Marseille Université, Institut Paoli-Calmettes, Marseille, France.
Collette Y; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique U7258, Aix Marseille Université, Institut Paoli-Calmettes, Marseille, France.
Bouabdallah R; Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
Schiano JM; Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
Bonnet N; Department of Dermatology, Aix Marseille University, Assistance Publique-Hôpitaux de Marseille, Hôpital Nord, Marseille, France.
Grob JJ; Department of Dermatology and Skin Cancers, Hôpital de la Timone, Aix Marseille Université, Marseille, France.
Gaulard P; Department of Pathology and INSERM U955 Team 9 and.
Bagot M; Department of Dermatology, Saint-Louis Hospital, AP-HP, Paris University, INSERM U976, Paris, France; and.
Bensussan A; Paris University, INSERM, UMR-976, Institut de Recherche Saint-Louis, Paris, France.
Berbis P; Department of Dermatology, Aix Marseille University, Assistance Publique-Hôpitaux de Marseille, Hôpital Nord, Marseille, France.
Olive D; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique U7258, Aix Marseille Université, Institut Paoli-Calmettes, Marseille, France.
Pokaż więcej
Źródło :
Blood advances [Blood Adv] 2020 Oct 27; Vol. 4 (20), pp. 5203-5214.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Lymphoma, T-Cell, Cutaneous*/drug therapy
Mycosis Fungoides*
Sezary Syndrome*/drug therapy
Skin Neoplasms*/drug therapy
Animals ; Humans ; Inducible T-Cell Co-Stimulator Protein ; Mice
Czasopismo naukowe
Tytuł :
Emerging Role of T-cell Receptor Constant β Chain-1 (TRBC1) Expression in the Flow Cytometric Diagnosis of T-cell Malignancies.
Autorzy :
Horna P; Division of Hematopathology, Mayo Clinic, Rochester, MN 55905, USA.
Shi M; Division of Hematopathology, Mayo Clinic, Rochester, MN 55905, USA.
Olteanu H; Division of Hematopathology, Mayo Clinic, Rochester, MN 55905, USA.
Johansson U; SI-HMDS, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol BS1 3NU, UK.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Feb 12; Vol. 22 (4). Date of Electronic Publication: 2021 Feb 12.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Lymphoma, T-Cell*/diagnosis
Lymphoma, T-Cell*/metabolism
Lymphoma, T-Cell*/pathology
Neoplasm Proteins/*biosynthesis
Receptors, Antigen, T-Cell, alpha-beta/*biosynthesis
T-Lymphocytes/*metabolism
Humans ; T-Lymphocytes/pathology
Czasopismo naukowe
Tytuł :
PD-L1 expression on tumor or stromal cells of nodal cytotoxic T-cell lymphoma: A clinicopathological study of 50 cases.
Autorzy :
Yamashita D; Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Aichi, Japan.; Department of Pathology, Kobe City Hospital Organization Kobe City Medical Center General Hospital, Hyōgo, Japan.
Shimada K; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Aichi, Japan.
Kohno K; Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Aichi, Japan.
Kogure Y; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.
Kataoka K; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.
Takahara T; Department of Surgical Pathology, Aichi Medical University Hospital, Aichi, Japan.
Suzuki Y; Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Aichi, Japan.
Satou A; Department of Surgical Pathology, Aichi Medical University Hospital, Aichi, Japan.
Sakakibara A; Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Aichi, Japan.
Nakamura S; Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Aichi, Japan.
Asano N; Department of Molecular Diagnostics, Nagano Prefectural Suzaka Hospital, Nagano, Japan.
Kato S; Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Aichi, Japan.; Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Aichi, Japan.
Pokaż więcej
Źródło :
Pathology international [Pathol Int] 2020 Aug; Vol. 70 (8), pp. 513-522. Date of Electronic Publication: 2020 May 18.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Lymphoma, T-Cell, Peripheral*/diagnosis
Lymphoma, T-Cell, Peripheral*/metabolism
Lymphoma, T-Cell, Peripheral*/pathology
B7-H1 Antigen/*metabolism
Adult ; Aged ; Biomarkers, Tumor/metabolism ; Epstein-Barr Virus Infections/diagnosis ; Epstein-Barr Virus Infections/pathology ; Female ; Humans ; Lymphoma, T-Cell/diagnosis ; Lymphoma, T-Cell/metabolism ; Lymphoma, T-Cell/pathology ; Male ; Middle Aged ; Prognosis
Czasopismo naukowe
Tytuł :
T cell receptor diversity, specificity and promiscuity of functionally heterogeneous human MR1-restricted T cells.
Autorzy :
Lepore M; Immunocore Ltd Milton Park, Abingdon, United Kingdom. Electronic address: .
Lewinsohn DA; Department of Pediatrics, Oregon Health & Science University, Portland, OR, United States.
Lewinsohn DM; Department of Medicine, Oregon Health & Science University, Portland VA Medical Center, Portland, OR, United States. Electronic address: .
Pokaż więcej
Źródło :
Molecular immunology [Mol Immunol] 2021 Feb; Vol. 130, pp. 64-68. Date of Electronic Publication: 2020 Dec 23.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Histocompatibility Antigens Class I/*metabolism
Minor Histocompatibility Antigens/*metabolism
Mucosal-Associated Invariant T Cells/*metabolism
Receptors, Antigen, T-Cell/*immunology
T-Cell Antigen Receptor Specificity/*physiology
T-Lymphocyte Subsets/*immunology
Histocompatibility Antigens Class I/immunology ; Humans ; Immunity, Mucosal/immunology ; Minor Histocompatibility Antigens/immunology ; Mucosal-Associated Invariant T Cells/immunology ; Receptors, Antigen, T-Cell/physiology ; Receptors, Antigen, T-Cell, alpha-beta
Czasopismo naukowe
Tytuł :
The molecular assembly of the marsupial γμ T cell receptor defines a third T cell lineage.
Autorzy :
Morrissey KA; Department of Biology, Center for Evolutionary and Theoretical Immunology, University of New Mexico, Albuquerque, NM, USA.
Wegrecki M; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Praveena T; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria, Australia.
Hansen VL; Department of Biology, Center for Evolutionary and Theoretical Immunology, University of New Mexico, Albuquerque, NM, USA.
Bu L; Department of Biology, Center for Evolutionary and Theoretical Immunology, University of New Mexico, Albuquerque, NM, USA.
Sivaraman KK; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Darko S; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Douek DC; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Rossjohn J; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia. .; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria, Australia.; Institute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff, UK.
Miller RD; Department of Biology, Center for Evolutionary and Theoretical Immunology, University of New Mexico, Albuquerque, NM, USA. .
Le Nours J; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia. .; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria, Australia.
Pokaż więcej
Źródło :
Science (New York, N.Y.) [Science] 2021 Mar 26; Vol. 371 (6536), pp. 1383-1388.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Monodelphis/*immunology
Receptors, Antigen, T-Cell/*chemistry
T-Lymphocyte Subsets/*immunology
Animals ; Cell Lineage ; Complementarity Determining Regions/chemistry ; Crystallography, X-Ray ; Models, Molecular ; Monodelphis/genetics ; Protein Conformation ; Protein Domains ; Protein Multimerization ; Receptors, Antigen, T-Cell/genetics ; Receptors, Antigen, T-Cell/immunology ; Receptors, Antigen, T-Cell, alpha-beta ; Receptors, Antigen, T-Cell, gamma-delta
Czasopismo naukowe
Tytuł :
Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells.
Autorzy :
Best S; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Lam V; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Liu T; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Bruss N; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Kittai A; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Danilova OV; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Murray S; University of Portland, Portland, OR, USA.
Berger A; Millennium Pharmaceuticals, Inc., Cambridge, MA, USA.
Pennock ND; Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, OR, USA.
Lind EF; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Danilov AV; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. .; City of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, 91010, USA. .
Pokaż więcej
Źródło :
Leukemia [Leukemia] 2021 Jan; Vol. 35 (1), pp. 156-168. Date of Electronic Publication: 2020 Mar 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents/*pharmacology
Cyclopentanes/*pharmacology
Immunomodulation/*drug effects
Leukemia, Prolymphocytic, T-Cell/*immunology
Leukemia, Prolymphocytic, T-Cell/*metabolism
NEDD8 Protein/*antagonists & inhibitors
NEDD8 Protein/*metabolism
Pyrimidines/*pharmacology
Antineoplastic Agents/therapeutic use ; Cell Line, Tumor ; Cyclopentanes/therapeutic use ; Enzyme Inhibitors/pharmacology ; Enzyme Inhibitors/therapeutic use ; Humans ; Leukemia, Prolymphocytic, T-Cell/drug therapy ; Leukemia, Prolymphocytic, T-Cell/pathology ; Lymphocyte Activation/drug effects ; Lymphocyte Activation/immunology ; Models, Biological ; Pyrimidines/therapeutic use ; Receptors, Antigen, T-Cell/metabolism ; Signal Transduction ; T-Lymphocytes/drug effects ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism ; T-Lymphocytes/pathology ; T-Lymphocytes, Helper-Inducer/drug effects ; T-Lymphocytes, Helper-Inducer/immunology ; T-Lymphocytes, Helper-Inducer/metabolism
Czasopismo naukowe
Tytuł :
Replacement of TCR Dβ With Immunoglobulin D H DSP2.3 Imposes a Tyrosine-Enriched TCR Repertoire and Adversely Affects T Cell Development.
Autorzy :
Levinson M; Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Khass M; Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.; Division of Genetic Engineering and Biotechnology, National Research Center, Cairo, Egypt.
Burrows PD; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, United States.
Schroeder HW Jr; Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2020 Sep 29; Vol. 11, pp. 573413. Date of Electronic Publication: 2020 Sep 29 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Complementarity Determining Regions*
Genes, Immunoglobulin Heavy Chain*
Genes, T-Cell Receptor beta*
Immunoglobulin Heavy Chains/*metabolism
Receptors, Antigen, T-Cell, alpha-beta/*metabolism
T-Lymphocytes/*metabolism
Thymocytes/*metabolism
Animals ; Immunization ; Immunodominant Epitopes ; Immunoglobulin Heavy Chains/genetics ; Lymphocyte Activation ; Mice, Inbred C57BL ; Mice, Knockout ; Ovalbumin/administration & dosage ; Ovalbumin/immunology ; Phenotype ; Receptors, Antigen, T-Cell, alpha-beta/genetics ; T-Lymphocytes/immunology ; Thymocytes/immunology ; Tyrosine
Czasopismo naukowe
Tytuł :
TCR-Seq Identifies Distinct Repertoires of Distant-Metastatic and Nondistant-Metastatic Thyroid Tumors.
Autorzy :
Lan X; Department of Head and Neck Surgery, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.; Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences Hangzhou, China.
Cao J; Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences Hangzhou, China.
Ye K; Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences Hangzhou, China.; Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Zhang C; Geneplus-Shenzhen, Shenzhen, China.
Zhang Q; Zhejiang Chinese Medical University, Hangzhou, China.
Ge X; Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences Hangzhou, China.; Heartland Christian School, Columbiana, Ohio, USA.
Wang C; Geneplus-Shenzhen, Shenzhen, China.; School of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, China.
Zhang C; Geneplus-Beijing, Beijing, China.
Tai Z; Geneplus-Shenzhen, Shenzhen, China.
Wei W; Geneplus-Shenzhen, Shenzhen, China.
Huang Y; Geneplus-Shenzhen, Shenzhen, China.
Yi X; Geneplus-Shenzhen, Shenzhen, China.
Tan Z; Department of Head and Neck Surgery, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
Zheng C; Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang Province, China.
Chen C; Department of Head and Neck Surgery, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
Zhu X; Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences Hangzhou, China.
Wang J; Department of Head and Neck Surgery, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
Xu J; Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang Province, China.
Zhu X; Department of Head and Neck Surgery, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
Ge M; Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang Province, China.
Pokaż więcej
Źródło :
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2020 Sep 01; Vol. 105 (9).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Genes, T-Cell Receptor beta*
Lymphocytes, Tumor-Infiltrating/*metabolism
Thyroid Cancer, Papillary/*genetics
Thyroid Cancer, Papillary/*pathology
Thyroid Neoplasms/*genetics
Thyroid Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Case-Control Studies ; Female ; Gene Expression Regulation, Neoplastic ; High-Throughput Nucleotide Sequencing ; Humans ; Lymphocytes, Tumor-Infiltrating/pathology ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/pathology ; Receptors, Antigen, T-Cell/genetics ; Receptors, Antigen, T-Cell/metabolism ; Retrospective Studies ; Thyroid Nodule/genetics ; Thyroid Nodule/pathology
Czasopismo naukowe
Tytuł :
Absence of αβ T cells accelerates disuse bone loss in male mice after spinal cord injury.
Autorzy :
Sahbani K; National Center for the Medical Consequences of Spinal Cord Injury, James J Peters Veterans Affairs Medical Center, Bronx, New York.; Bronx Veterans Medical Research Foundation Inc., Bronx, New York.
Shultz LC; Veterinary Medical Unit, James J Peters Veterans Affairs Medical Center, Bronx, New York.
Cardozo CP; National Center for the Medical Consequences of Spinal Cord Injury, James J Peters Veterans Affairs Medical Center, Bronx, New York.; Bronx Veterans Medical Research Foundation Inc., Bronx, New York.; Department of Medicine, The Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Rehabilitation Medicine and Human Performance, The Icahn School of Medicine at Mount Sinai, New York, New York.
Bauman WA; National Center for the Medical Consequences of Spinal Cord Injury, James J Peters Veterans Affairs Medical Center, Bronx, New York.; Bronx Veterans Medical Research Foundation Inc., Bronx, New York.; Department of Medicine, The Icahn School of Medicine at Mount Sinai, New York, New York.
Tawfeek HA; National Center for the Medical Consequences of Spinal Cord Injury, James J Peters Veterans Affairs Medical Center, Bronx, New York.; Bronx Veterans Medical Research Foundation Inc., Bronx, New York.; Department of Medicine, The Icahn School of Medicine at Mount Sinai, New York, New York.
Pokaż więcej
Źródło :
Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2021 Mar; Vol. 1487 (1), pp. 43-55. Date of Electronic Publication: 2020 Oct 26.
Typ publikacji :
Journal Article
MeSH Terms :
Bone Resorption/*genetics
Genes, T-Cell Receptor beta/*genetics
Spinal Cord Injuries/*complications
T-Lymphocytes/*pathology
Animals ; Bone Density/genetics ; Bone Density/immunology ; Bone Diseases, Metabolic/genetics ; Bone Diseases, Metabolic/immunology ; Bone Diseases, Metabolic/metabolism ; Bone Diseases, Metabolic/pathology ; Bone Resorption/immunology ; Bone Resorption/metabolism ; Cell Count ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Receptors, Antigen, T-Cell, alpha-beta/deficiency ; Receptors, Antigen, T-Cell, alpha-beta/genetics ; Receptors, Antigen, T-Cell, alpha-beta/metabolism ; Spinal Cord Injuries/genetics ; Spinal Cord Injuries/immunology ; Spinal Cord Injuries/metabolism ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism ; X-Ray Microtomography
Czasopismo naukowe
Tytuł :
The Invariant NKT Cell Response Has Differential Signaling Requirements during Antigen-Dependent and Antigen-Independent Activation.
Autorzy :
Anderson CK; Department of Molecular Microbiology and Immunology, Division of Biology and Medicine, Brown University, Providence, RI 02906.
Reilly SP; Department of Molecular Microbiology and Immunology, Division of Biology and Medicine, Brown University, Providence, RI 02906.
Brossay L; Department of Molecular Microbiology and Immunology, Division of Biology and Medicine, Brown University, Providence, RI 02906 .
Pokaż więcej
Źródło :
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2021 Jan 01; Vol. 206 (1), pp. 132-140. Date of Electronic Publication: 2020 Nov 23.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Natural Killer T-Cells/*immunology
Receptors, Antigen, T-Cell/*metabolism
Animals ; Antigens/immunology ; Cells, Cultured ; Interleukin-12/genetics ; Interleukin-12/metabolism ; Interleukin-18/metabolism ; Lymphocyte Activation ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Mice, Transgenic ; Myeloid Differentiation Factor 88/metabolism ; Receptors, Antigen, T-Cell/genetics ; Signal Transduction ; T-Cell Antigen Receptor Specificity
Czasopismo naukowe
Tytuł :
Stage IV natural killer/T-cell lymphoma with chronic active Epstein-Barr virus, treated with pembrolizumab and TCRαβ-depleted haploidentical hematopoietic stem cell transplantation.
Autorzy :
Kim YE; Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center Children's Hospital, Seoul, Republic of Korea.
Kim H; Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center Children's Hospital, Seoul, Republic of Korea.; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Shin J; Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center Children's Hospital, Seoul, Republic of Korea.; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Min SY; Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center Children's Hospital, Seoul, Republic of Korea.; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Kang SH; Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center Children's Hospital, Seoul, Republic of Korea.; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Suh JK; Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center Children's Hospital, Seoul, Republic of Korea.; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Koh KN; Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center Children's Hospital, Seoul, Republic of Korea.; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Im HJ; Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center Children's Hospital, Seoul, Republic of Korea.; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2020 Sep; Vol. 61 (9), pp. 2250-2253. Date of Electronic Publication: 2020 Apr 30.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Epstein-Barr Virus Infections*/complications
Hematopoietic Stem Cell Transplantation*
Lymphoma, T-Cell*
Antibodies, Monoclonal, Humanized ; Herpesvirus 4, Human ; Humans ; Killer Cells, Natural ; Receptors, Antigen, T-Cell, alpha-beta/genetics
Raport
Tytuł :
The new biology of PTCL-NOS and AITL: current status and future clinical impact.
Autorzy :
Timmins MA; Leicester Cancer Research Centre, Ernest and Helen Scott Haematology Research Institute, University of Leicester, Leicester, UK.
Wagner SD; Leicester Cancer Research Centre, Ernest and Helen Scott Haematology Research Institute, University of Leicester, Leicester, UK.
Ahearne MJ; Leicester Cancer Research Centre, Ernest and Helen Scott Haematology Research Institute, University of Leicester, Leicester, UK.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2020 Apr; Vol. 189 (1), pp. 54-66. Date of Electronic Publication: 2020 Feb 17.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Lymphoma, T-Cell, Peripheral*/classification
Lymphoma, T-Cell, Peripheral*/genetics
Lymphoma, T-Cell, Peripheral*/immunology
Lymphoma, T-Cell, Peripheral*/therapy
Mutation, Missense*
Neoplasm Proteins*/genetics
Neoplasm Proteins*/immunology
rhoA GTP-Binding Protein*/genetics
rhoA GTP-Binding Protein*/immunology
Epigenesis, Genetic/*immunology
Gene Expression Regulation, Neoplastic/*immunology
T-Lymphocytes, Helper-Inducer/*immunology
Humans ; Receptors, Antigen, T-Cell/genetics ; Receptors, Antigen, T-Cell/immunology ; Signal Transduction/genetics ; Signal Transduction/immunology
Czasopismo naukowe
Tytuł :
Benchmarking of T cell receptor repertoire profiling methods reveals large systematic biases.
Autorzy :
Barennes P; Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy (i3), Paris, France.; AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (i2B), Paris, France.
Quiniou V; Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy (i3), Paris, France.; AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (i2B), Paris, France.
Shugay M; Center of Life Sciences, Skoltech, Moscow, Russia.; Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Russian National Research Medical University, Moscow, Russia.
Egorov ES; Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
Davydov AN; Adaptive Immunity Group, Central European Institute of Technology, Brno, Czechia.
Chudakov DM; Center of Life Sciences, Skoltech, Moscow, Russia.; Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Russian National Research Medical University, Moscow, Russia.; Adaptive Immunity Group, Central European Institute of Technology, Brno, Czechia.
Uddin I; Division of Infection and Immunity, University College London, London, UK.
Ismail M; Division of Infection and Immunity, University College London, London, UK.
Oakes T; Division of Infection and Immunity, University College London, London, UK.
Chain B; Division of Infection and Immunity, University College London, London, UK.
Eugster A; DFG-Centre for Regenerative Therapies Dresden, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Kashofer K; Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Rainer PP; Division of Cardiology, Medical University of Graz, Graz, Austria.; BioTechMed-Graz, Graz, Austria.
Darko S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Ransier A; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Douek DC; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Klatzmann D; Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy (i3), Paris, France.; AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (i2B), Paris, France.
Mariotti-Ferrandiz E; Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy (i3), Paris, France. .; AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (i2B), Paris, France. .
Pokaż więcej
Źródło :
Nature biotechnology [Nat Biotechnol] 2021 Feb; Vol. 39 (2), pp. 236-245. Date of Electronic Publication: 2020 Sep 07.
Typ publikacji :
Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms :
High-Throughput Nucleotide Sequencing/*methods
Receptors, Antigen, T-Cell/*genetics
Adult ; Bias ; Computer Simulation ; Humans ; Jurkat Cells ; Male ; Middle Aged ; Receptors, Antigen, T-Cell, alpha-beta/genetics ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
Phase II study of E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma.
Autorzy :
Kawai H; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
Ando K; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
Maruyama D; Department of Hematology, National Cancer Center Hospital, National Cancer Center Hospital, Tokyo, Japan.
Yamamoto K; Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
Kiyohara E; Department of Dermatology, Osaka University Hospital, Osaka, Japan.
Terui Y; Department of Hematology Oncology, The Cancer Institute Hospital of JFCR, Tokyo, Japan.
Fukuhara N; Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan.
Miyagaki T; Department of Dermatology, The University of Tokyo Hospital, Tokyo, Japan.
Tokura Y; Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Sakata-Yanagimoto M; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan.
Igarashi T; Department of Hematology, Gunma Cancer Center, Ota, Japan.
Kuroda J; Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Fujita J; Department of Dermatology, Osaka University Hospital, Osaka, Japan.
Uchida T; Department of Hematology and Oncology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
Ishikawa T; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
Yonekura K; Department of Dermatology, Imamura General Hospital, Kagoshima, Japan.
Kato K; Department of Hematology and Oncology, Kyushu University Hospital, Fukuoka, Japan.
Nakanishi T; Eisai Co., Ltd., Tokyo, Japan.
Nakai K; Eisai Co., Ltd., Tokyo, Japan.
Matsunaga R; Eisai Co., Ltd., Tokyo, Japan.
Tobinai K; Department of Hematology, National Cancer Center Hospital, National Cancer Center Hospital, Tokyo, Japan.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Jun; Vol. 112 (6), pp. 2426-2435. Date of Electronic Publication: 2021 May 03.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study
MeSH Terms :
Lymphoma, T-Cell, Cutaneous/*drug therapy
Lymphoma, T-Cell, Peripheral/*drug therapy
Neoplasm Recurrence, Local/*drug therapy
Recombinant Fusion Proteins/*administration & dosage
Administration, Intravenous ; Binding Sites ; Diphtheria Toxin/chemistry ; Diphtheria Toxin/genetics ; Drug Administration Schedule ; Female ; Humans ; Interleukin-2/chemistry ; Interleukin-2/genetics ; Japan ; Lymphoma, T-Cell, Cutaneous/blood ; Lymphoma, T-Cell, Peripheral/blood ; Male ; Neoplasm Recurrence, Local/blood ; Recombinant Fusion Proteins/adverse effects ; Recombinant Fusion Proteins/pharmacokinetics ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Peptide-MHC Binding Reveals Conserved Allosteric Sites in MHC Class I- and Class II-Restricted T Cell Receptors (TCRs).
Autorzy :
He Y; W.M. Keck Laboratory for Structural Biology, University of Maryland Institute for Bioscience and Biotechnology Research, Rockville, MD 20850, USA; Department of Chemistry and Biochemistry, University of Maryland, College Park, MD 20742, USA.
Agnihotri P; W.M. Keck Laboratory for Structural Biology, University of Maryland Institute for Bioscience and Biotechnology Research, Rockville, MD 20850, USA; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA.
Rangarajan S; W.M. Keck Laboratory for Structural Biology, University of Maryland Institute for Bioscience and Biotechnology Research, Rockville, MD 20850, USA; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA.
Chen Y; W.M. Keck Laboratory for Structural Biology, University of Maryland Institute for Bioscience and Biotechnology Research, Rockville, MD 20850, USA; Department of Chemistry and Biochemistry, University of Maryland, College Park, MD 20742, USA.
Kerzic MC; W.M. Keck Laboratory for Structural Biology, University of Maryland Institute for Bioscience and Biotechnology Research, Rockville, MD 20850, USA; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA.
Ma B; Engineering Research Center of Cell & Therapeutic Antibody, MOE, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China; Computational Structural Biology Section, Frederick National Laboratory for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702, USA.
Nussinov R; Computational Structural Biology Section, Frederick National Laboratory for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702, USA.
Mariuzza RA; W.M. Keck Laboratory for Structural Biology, University of Maryland Institute for Bioscience and Biotechnology Research, Rockville, MD 20850, USA; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA. Electronic address: .
Orban J; W.M. Keck Laboratory for Structural Biology, University of Maryland Institute for Bioscience and Biotechnology Research, Rockville, MD 20850, USA; Department of Chemistry and Biochemistry, University of Maryland, College Park, MD 20742, USA. Electronic address: .
Pokaż więcej
Źródło :
Journal of molecular biology [J Mol Biol] 2020 Dec 04; Vol. 432 (24), pp. 166697. Date of Electronic Publication: 2020 Nov 04.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Histocompatibility Antigens Class I/*immunology
Histocompatibility Antigens Class II/*immunology
Peptides/*immunology
Receptors, Antigen, T-Cell, alpha-beta/*immunology
Allosteric Site/genetics ; Binding Sites/genetics ; Conserved Sequence/genetics ; HLA-DR4 Antigen/genetics ; HLA-DR4 Antigen/immunology ; Histocompatibility Antigens Class I/genetics ; Histocompatibility Antigens Class II/genetics ; Humans ; Molecular Dynamics Simulation ; Peptides/genetics ; Protein Binding/genetics ; Protein Conformation ; Receptor-CD3 Complex, Antigen, T-Cell/immunology ; Receptors, Antigen, T-Cell, alpha-beta/genetics ; T-Lymphocytes/immunology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies